Cart
sales@molnova.com
MuRF1-IN-1
CAS No. 445222-91-3
MuRF1-IN-1( —— )
Catalog No. M24407 CAS No. 445222-91-3
MuRF1-IN-1 is an inhibitor of muscle ring finger 1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 147 | In Stock |
|
| 10MG | 237 | In Stock |
|
| 25MG | 483 | In Stock |
|
| 50MG | 698 | In Stock |
|
| 100MG | 972 | In Stock |
|
| 500MG | 1953 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMuRF1-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionMuRF1-IN-1 is an inhibitor of muscle ring finger 1.
-
DescriptionMuRF1-IN-1 is an inhibitor of muscle ring finger 1.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorMuRF1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number445222-91-3
-
Formula Weight321.33
-
Molecular FormulaC18H15N3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (389.01 mM)
-
SMILESCN(C(C12C(C#N)=C(N)OC(CCC3)=C1C3=O)=O)c1c2cccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bowen TS, Adams V, Werner S, et al. Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia. J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):939-953.
molnova catalog
related products
-
Angelic anhydride
Angelic Anhydride is a reagent in the improved synthesis of angelate esters, which are the active chemical behind the strong pain-relieving and spasmolytic action of extracts from the plant butterbur.
-
Gefapixant citrate
Gefapixant citrate is an orally active P2X3 receptor (P2X3R) antagonist that acts on human homologous recombinant hP2X3 (IC50: ~30 nM) and hP2X2/3 (IC50: 100-200 nM).
-
Benzenepentacarboxyl...
Benzenepentacarboxylic acid is a novel fluorescent probe to detect and scavenge HO-. Benzenepentacarboxylic acid is utilized to prove and detect the generation of HO- in H2O2/TAED and H2O2/TBCC alkali systems.
